The same applies to the transcription factor PPARdelta that has been shown to promote tumor progression of colorectal cancer, breast cancer and cervical cancer by activating ASCT2 and GLUT1 expression (Zhang et al., 2017). Here, SLC2A1 is linked to breast carcinoma.